Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial

Christoph Herrmann‐Lingen1, Christian Albus2, Martina de Zwaan3, Franziska Geiser4, Katrin Heinemann1, Martin Hellmich5, Matthias Michal6, Monika Sadlonova7, Ralf Tostmann8, Rolf Wachter9, Bea Herbeck Belnap10
1Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Von-Siebold-Str. 5, 37075, Göttingen, Germany
2Department of Psychosomatics and Psychotherapy, University of Cologne, Cologne, Germany
3Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany
4Department of Psychosomatic Medicine and Psychotherapy, University of Bonn Medical Center, Bonn, Germany
5Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany
6Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Mainz, Mainz, Germany
7German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany
8Clinical Trials Unit, University of Göttingen Medical Center, Göttingen, Germany
9Clinic and Policlinic for Cardiology, University Hospital of Leipzig, Leipzig, Germany
10Center for Behavioral Health, Media, and Technology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

Tóm tắt

Abstract Background Coronary heart disease (CHD) is the leading cause of death and years of life lost worldwide. While effective treatments are available for both acute and chronic disease stages there are unmet needs for effective interventions to support patients in health behaviors required for secondary prevention. Psychosocial distress is a common comorbidity in patients with CHD and associated with substantially reduced health-related quality of life (HRQoL), poor health behavior, and low treatment adherence. Methods In a confirmatory, randomized, controlled, two-arm parallel group, multicenter behavioral intervention trial we will randomize 440 distressed CHD patients with at least one insufficiently controlled cardiac risk factor to either their physicians' usual care (UC) or UC plus 12-months of blended collaborative care (TeamCare = TC). Trained nurse care managers (NCM) will proactively support patients to identify individual sources of distress and risk behaviors, establish a stepwise treatment plan to improve self-help and healthy behavior, and actively monitor adherence and progress. Additional e-health resources are available to patients and their families. Intervention fidelity is ensured by a treatment manual, an electronic patient registry, and a specialist team regularly supervising NCM via videoconferences and recommending protocol and guideline-compliant treatment adjustments as indicated. Recommendations will be shared with patients and their physicians who remain in charge of patients’ care. Since HRQoL is a recommended outcome by both, several guidelines and patient preference we chose a ≥ 50% improvement over baseline on the HeartQoL questionnaire at 12 months as primary outcome. Our primary hypothesis is that significantly more patients receiving TC will meet the primary outcome criterion compared to the UC group. Secondary hypotheses will evaluate improvements in risk factors, psychosocial variables, health care utilization, and durability of intervention effects over 18–30 months of follow-up. Discussion TEACH is the first study of a blended collaborative care intervention simultaneously addressing distress and medical CHD risk factors conducted in cardiac patients in a European health care setting. If proven effective, its results can improve long-term chronic care of this vulnerable patient group and may be adapted for patients with other chronic conditions. Trial registration: German Clinical Trials Register, DRKS00020824, registered on 4 June, 2020; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00020824

Từ khóa


Tài liệu tham khảo

Gößwald A, Schienkiewitz A, Nowossadeck E, Busch MA. Prävalenz von Herzinfarkt und koronarer Herzkrankheit bei Erwachsenen im Alter von 40 bis 79 Jahren in Deutschland. Bundesgesundheitsbl. 2013;56:650–5.

WHO Health statistics and information systems. Estimates for 2000–2016. http://www.who.int/healthinfo/global_burden_disease/estimates/en/. Accessed 1/25/2019.

Statistisches Bundesamt. Krankheitskostenrechnung, Table 23631-0001. 2018 https://www-genesis.destatis.de. Accessed 01/25/2019.

Herrmann-Lingen C, Beutel ME, Bosbach A, Deter HC, Fritzsche K, Hellmich M, Jordan J, Jünger J, Ladwig KH, Michal M, Petrowski K, Pieske B, Ronel J, Söllner W, Stöhr A, Weber C, de Zwaan M, Albus C; SPIRR-CAD Study Group. A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD)—Results of an observer-blinded, multicenter, randomized trial in depressed patients with CAD. Psychosom Med. 2016;78:704–15.

Crawshaw J, Auyeung V, Norton S, Weinman J. Identifying psychosocial predictors of medication non-adherence following acute coronary syndrome: a systematic review and meta-analysis. J Psychosom Res. 2016;90:10–32.

Sin NL, Kumar AD, Gehi AK, Whooley MA. Direction of association between depressive symptoms and lifestyle behaviors in patients with coronary heart disease: the heart and soul study. Ann Behav Med. 2016;50:523–32.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;2016(37):2315–81.

Mittag O, Schramm S, Böhmen S, Hüppe A, Meyer T, Raspe H. Medium-term effects of cardiac rehabilitation in Germany: systematic review and meta- analysis of results from national and international studies. Eur J Cardiovasc Prev Rehabil. 2011;18:587–93.

Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. BMJ Open. 2015;5:e009128.

Carney RM, Freedland KE, Steinmeyer BC, Rubin EH, Ewald G. Collaborative care for depression symptoms in an outpatient cardiology setting: a randomized clinical trial. Int J Cardiol. 2016;219:164–71.

Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611–20.

Katon WJ, Russo J, Lin EH, Schmittdiel J, Ciechanowski P, Ludman E, Peterson D, Young B, Von Korff M. Cost-effectiveness of a multicondition collaborative care intervention. Arch Gen Psychiatry. 2012;69:506–14.

Fangauf SV, Herrmann-Lingen C, Belnap BH. Ganzheitliche Langzeitbehandlung bei koronarer Herzkrankheit durch TeamCare. Machbarkeit im Rahmen des deutschen Gesundheitssystems. Psychotherapeut 2017;62:528–36.

Bosselmann L, Fangauf SV, Herbeck Belnap B, Chavanon ML, Nagel J, Neitzel C, Schertz A, Hummers E, Wachter R, Herrmann-Lingen C. Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: results of a randomized feasibility study. Eur J Cardiovasc Nurs. 2020;19:134–41.

Rollman BL, Herbeck Belnap B, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, Kapoor WN, Schulberg HC, Reynolds CF 3rd. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA. 2009;302:2095–103.

Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med. 2010;170:600–8.

Herbeck Belnap B, Anderson A, Abebe KZ, et al. Blended collaborative care to treat heart failure and comorbid depression: rationale and study design of the hopeful heart trial. Psychosom Med. 2019;81:495–505.

Herrmann-Lingen C, Buss U, Snaith R.P. HADS-D. Hospital anxiety and depression scale—Deutsche Version. Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R. P. Snaith und A. S. Zigmond. 4. Aktualisierte Auflage. Bern: Hogrefe; 2018

Warttig SL, Forshaw MJ, South J, White AK. New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4). J Health Psychol. 2013;8:1617–28.

Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Chronische Koronare Herzkrankheit: KHK. Patientenleitlinie zur Nationalen VersorgungsLeitlinie, 3. Auflage. Version 1. 2019b. https://doi.org/10.6101/AZQ/000460. www.khk.versorgungsleitlinien.de. Accessed: 02.09.2020.

Bundesärztekammer, Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Chronische KHK—Langfassung, 5. Auflage,. 2019. www.khk.versorgungsleitlinien.de. Accessed: 2020/01/10.

Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prevent Cardiol. 2014;21:98–106.

De Smedt D, Clays E, Höfer S, Oldridge N, Kotseva K, Maggioni AP, Janssen B, De Bacquer D; EUROASPIRE Investigators. Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology. Eur J Prev Cardiol. 2016;23:714–21.

Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105:310–5.

Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS medicine. 2008;5(1):e12.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

Herrmann C. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.

Barth J, Martin C.R. Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients. Health Qual Life Outcomes. 2005;3:15.

Hinz A, Zweynert U, Kittel J, Igl W, Schwarz R. Measurement of change with the hospital anxiety and depression scale (HADS): sensitivity and reliability of change. Psychother Psychosom Med Psychol. 2008;59:394–400.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 2:69–77.

Ingram PB, Clarke E, Lichtenberg JW. Confirmatory factor analysis of the perceived stress scale-4 in a community sample. Stress Health. 2016;32:173–6.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.

Klein E. M, Brähler E, Dreier M, Reinecke L, Müller K.W, Schmutzer G, Wölfling K, Beutel, M.E. The German version of the Perceived Stress Scale–psychometric characteristics in a representative German community sample. BMC psychiatry. 2016;16:159.

ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD). Study design and methods. Am Heart J. 2000;139:1–9.

Cordes A, Herrmann-Lingen C, Büchner B, Hessel A. Repräsentative Normierung des ENRICHD-Social-Support-Instrument (ESSI)—Deutsche Version. Klin Diagnostik Eval. 2009;2:16–32.

Sorensen K, Van den Brouke S, Fullam J, Doyle G, Pelikan J, Slonska, Z, Brand H, for the HLS-EU Consortium Health Literacy Project Europe. Health Literacy and Public Health: A systematic Review and integration of definition and models. BMC Public Health 2012;12:80.

Röthlin F, Pelikan J.M, Ganahl K. Die Gesundheitskompetenz der 15-jährigen Jugendlichen in Österreich. Abschlussbericht der österreichischen Gesundheitskompetenz Jugendstudie im Auftrag des Hauptverbands der österreichischen Sozialversicherungsträger (HVSV). 2013. https://oepgk.at/wp-content/uploads/2020/02/bericht_die_gesundheitskompetenz_von_15-jaehrigen_jugendlich.pdf. Accessed 03/03/2020

Fraley RC, Shaver PR. Adult romantic attachment: theoretical developments, emerging controversies, and unanswered questions. Rev Gen Psychol. 2000;4:132–54.

Ehrenthal JC, Dinger U, Lamla A, Funken B, Schauenburg H. Evaluation der deutschsprachigen Version des Bindungsfragebogens “Experience in close relationship- Revised” (ECR-RD). Psychother Psychosom Med Psychol. 2008;59:215–23.

Wagnild GM, Young HM. Development and psychometric evaluation of the resilience scale. J Nurs Measure. 1993;1:165–78.

Leppert K, Koch B, Brähler E, Strauß B. Die Resilienzskala (RS)—Überprüfung der Langform RS-25 und einer Kurzform RS-13. Klin Diagnost Eval. 2008;1:226–43.

Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The demoralization scale: a report of its development and preliminary validation. J Palliat Care. 2004;20:269–76.

Mehnert A, Vehling S, Höcker A, Lehmann C, Koch U. Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. J Pain Sympt Manage. 2011;42:768–76.

Eifert GH, Thompson RN, Zvolensky MJ, Edwards K, Frazer NL, Haddad JW, Davig J. The cardiac anxiety questionnaire: development and preliminary validity. Behav Res Ther. 2000;38:1039–53.

Hoyer J, Eifert GH (2004). Herzangstfragebogen (HAF-17)—überarbeitete deutsche Version. https://psycharchives.org/bitstream/20.500.12034/377/2/PT_9005128_HAF-17_Fragebogen.pdf. Accessed 03/03/2020

Einsle F, Köllner V, Herzberg P, Bernardy K, Nitschke-Bertaud M, Dannemann S, Hoyer J. Psychometrische Analysen zum Herzangstfragebogen Verhaltensther Verhaltensmed. 2009;30:439–57.

Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 1994;74:1240–4.

Höfer S, Benzer W, Schüßler G, von Steinbüchel N, Oldridge NB. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Qual Life Res. 2003;12:199–212.

Glombiewski JA, Nestoriuc Y, Rief W, Glaesmer H, Braehler E. Medication adherence in the general population. PLoS ONE. 2012;7:e50537.

Horvath AO, Greenberg LS. The development of the Working Alliance Inventory. In: Greenberg LS, Pinsof WM, editors. The psychotherapeutic process: a research handbook. New York, NY: Guilford; 1986. p. 529–56.

Wilmers F, Munder T, Leonhart R, Herzog T, Plassmann R, Barth J, Linster HW. Die deutschsprachige Version des Working Alliance Inventory—short revised (WAI-SR)—Ein schulenübergreifendes, ökonomisches und empirisch validiertes Instrument zur Erfassung der therapeutischen Allianz. Klin Diagnost Eval. 2008;1:343–58.

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exer. 2003;35:1381–95.

Ehrenthal JC, Dinger U, Schauenburg H, Horsch L, Dahlbender RW, Gierk B. Entwicklung einer Zwölf-Item-Version des OPD-Strukturfragebogens (OPD-SFK). Z Psychosom Med Psychother. 2015;61:262–74.

Ehrenthal JC, Düx A, Baie L, Burgmer M. Levels of personality functioning and not depression predict decline of plasma glucose concentration in patients with type 2 diabetes mellitus. Diab Res and Clin Pract. 2019;15:106–13.

Sv B. Flexible imputation of missing data. Boca Raton, FL: CRC Press; 2012.

Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clinical trials. 2005;2:152–62.

Ristl R, Urach S, Rosenkranz G, Posch M. Methods for the analysis of multiple endpoints in small populations: A review. J Biopharm Stat. 2019;29:1–29.

Murray MIK, Thalmann IN, Mossialos EA, Zeiher AM. Comorbidities of coronary heart disease and the impact on healthcare usage and productivity loss in a nationally-based study. Epidemiology (Sunnyvale). 2018;8:347.

Katon W, Lin EH, Von Korff M, Ciechanowski P, Ludman E, Young B, Rutter C, Oliver M, McGregor M. Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study. Contemp Clin Trials. 2010;31:312–22.

Stewart RAH, Colquhoun DM, Marschner SL, Kirby AC, Simes J, Nestel PJ, Glozier N, O'Neil A, Oldenburg B, White HD, Tonkin AM; LIPID Study Investigators. Persistent psychological distress and mortality in patients with stable coronary artery disease. Heart. 2017;103:1860–6.

Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived stress in myocardial infarction: long-term mortality and health status outcomes. J Am Coll Cardiol. 2012;60:1756–63.

Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–13.